[go: up one dir, main page]

DK179286D0 - Insulinpraeparat - Google Patents

Insulinpraeparat

Info

Publication number
DK179286D0
DK179286D0 DK179286A DK179286A DK179286D0 DK 179286 D0 DK179286 D0 DK 179286D0 DK 179286 A DK179286 A DK 179286A DK 179286 A DK179286 A DK 179286A DK 179286 D0 DK179286 D0 DK 179286D0
Authority
DK
Denmark
Prior art keywords
pct
insulin
sec
possibly
date dec
Prior art date
Application number
DK179286A
Other languages
Danish (da)
English (en)
Inventor
Per Balschmidt
Finn Benned Hansen
Bente Rose Johansen
Original Assignee
Nordisk Gentofte
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nordisk Gentofte filed Critical Nordisk Gentofte
Priority to DK179286A priority Critical patent/DK179286D0/da
Publication of DK179286D0 publication Critical patent/DK179286D0/da
Priority to CA000534467A priority patent/CA1283358C/fr
Priority to IL82209A priority patent/IL82209A0/xx
Priority to DE8787902450T priority patent/DE3772521D1/de
Priority to AU73561/87A priority patent/AU598543B2/en
Priority to AT87902450T priority patent/ATE66614T1/de
Priority to JP62502696A priority patent/JPH01500116A/ja
Priority to US07/132,969 priority patent/US5053389A/en
Priority to PCT/DK1987/000038 priority patent/WO1987006137A1/fr
Priority to EP87902450A priority patent/EP0267208B1/fr
Priority to ES8701124A priority patent/ES2007607A6/es
Priority to DK642587A priority patent/DK160460C/da
Priority to FI875533A priority patent/FI87529C/fi
Priority to NO875299A priority patent/NO875299L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Otolaryngology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
DK179286A 1986-04-18 1986-04-18 Insulinpraeparat DK179286D0 (da)

Priority Applications (14)

Application Number Priority Date Filing Date Title
DK179286A DK179286D0 (da) 1986-04-18 1986-04-18 Insulinpraeparat
CA000534467A CA1283358C (fr) 1986-04-18 1987-04-10 Preparation d'insuline
IL82209A IL82209A0 (en) 1986-04-18 1987-04-13 Insulin preparation
EP87902450A EP0267208B1 (fr) 1986-04-18 1987-04-14 Preparation d'insuline pour administration non parenterale
JP62502696A JPH01500116A (ja) 1986-04-18 1987-04-14 インシユリン製剤
AU73561/87A AU598543B2 (en) 1986-04-18 1987-04-14 An insulin preparation for non-parenteral administration
AT87902450T ATE66614T1 (de) 1986-04-18 1987-04-14 Insulinzubereitung fuer nicht-parenterale verabreichung.
DE8787902450T DE3772521D1 (de) 1986-04-18 1987-04-14 Insulinzubereitung fuer nicht-parenterale verabreichung.
US07/132,969 US5053389A (en) 1986-04-18 1987-04-14 Insulin preparation for non-parenteral administration
PCT/DK1987/000038 WO1987006137A1 (fr) 1986-04-18 1987-04-14 Preparation d'insuline pour administration non parenterale
ES8701124A ES2007607A6 (es) 1986-04-18 1987-04-15 Un procedimiento para la obtencion de un preparado de insulina para la administracion no parenteral.
DK642587A DK160460C (da) 1986-04-18 1987-12-08 Insulinpraeparat til nasal eller rektal administration og anvendelse af et insulinderivat til fremstilling af praeparatet
FI875533A FI87529C (fi) 1986-04-18 1987-12-16 Foerfarande foer framstaellning av ett insulinpreparat foer icke-parenteral administration
NO875299A NO875299L (no) 1986-04-18 1987-12-17 Insulinpreparat for ikke-paranteral administrasjon.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK179286A DK179286D0 (da) 1986-04-18 1986-04-18 Insulinpraeparat

Publications (1)

Publication Number Publication Date
DK179286D0 true DK179286D0 (da) 1986-04-18

Family

ID=8108089

Family Applications (2)

Application Number Title Priority Date Filing Date
DK179286A DK179286D0 (da) 1986-04-18 1986-04-18 Insulinpraeparat
DK642587A DK160460C (da) 1986-04-18 1987-12-08 Insulinpraeparat til nasal eller rektal administration og anvendelse af et insulinderivat til fremstilling af praeparatet

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK642587A DK160460C (da) 1986-04-18 1987-12-08 Insulinpraeparat til nasal eller rektal administration og anvendelse af et insulinderivat til fremstilling af praeparatet

Country Status (13)

Country Link
US (1) US5053389A (fr)
EP (1) EP0267208B1 (fr)
JP (1) JPH01500116A (fr)
AT (1) ATE66614T1 (fr)
AU (1) AU598543B2 (fr)
CA (1) CA1283358C (fr)
DE (1) DE3772521D1 (fr)
DK (2) DK179286D0 (fr)
ES (1) ES2007607A6 (fr)
FI (1) FI87529C (fr)
IL (1) IL82209A0 (fr)
NO (1) NO875299L (fr)
WO (1) WO1987006137A1 (fr)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69006662T2 (de) * 1989-08-21 1994-05-26 Hoffmann La Roche Insulinzubereitung für nicht-parenterale Verabreichung.
IL99699A (en) * 1990-10-10 2002-04-21 Autoimmune Inc Drug with the option of oral, intra-intestinal, or inhaled dosing for suppression of autoimmune response associated with type I diabetes
FR2686899B1 (fr) 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
US6131567A (en) * 1993-01-29 2000-10-17 Aradigm Corporation Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin
EP1607086A1 (fr) * 1993-01-29 2005-12-21 Aradigm Corporation Procédé d'utilisation d'insuline monomère en tant que moyen servant à améliorer la réproductibilité de l'insuline inhalée
TW404844B (en) 1993-04-08 2000-09-11 Oxford Biosciences Ltd Needleless syringe
US6893664B1 (en) 1996-06-17 2005-05-17 Powderject Research Limited Particle delivery techniques
US5948751A (en) * 1996-06-20 1999-09-07 Novo Nordisk A/S X14-mannitol
UA65549C2 (uk) * 1996-11-05 2004-04-15 Елі Ліллі Енд Компані Спосіб регулювання ожиріння шляхом периферійного введення аналогів та похідних glp-1 (варіанти) та фармацевтична композиція
SI0884053T1 (en) * 1997-06-13 2003-02-28 Eli Lilly And Company Stable insulin formulations
CO4750643A1 (es) * 1997-06-13 1999-03-31 Lilly Co Eli Formulacion estable de la insulina que contiene l-arginina y protamina
US20010053761A1 (en) * 1998-01-08 2001-12-20 Dimarchi Richard Dennis Method for administering aspb28-human insulin
US6350458B1 (en) 1998-02-10 2002-02-26 Generex Pharmaceuticals Incorporated Mixed micellar drug deliver system and method of preparation
US6221378B1 (en) 1998-02-10 2001-04-24 Generex Pharmaceuticals Incorporated Mixed micellar delivery system and method of preparation
US7070799B1 (en) * 1998-02-10 2006-07-04 Generex Pharmaceuticals, Inc. Method for administering insulin to the buccal region
US6451286B1 (en) 1998-12-21 2002-09-17 Generex Pharmaceuticals Incorporated Pharmaceutical compositions for buccal and pulmonary administration comprising an alkali metal alkyl sulfate and at least three micelle-forming compounds
US7087215B2 (en) * 1998-12-21 2006-08-08 Generex Pharmaceuticals Incorporated Methods of administering and enhancing absorption of pharmaceutical agents
US6849263B2 (en) * 1998-12-21 2005-02-01 Generex Pharmaceutical Incorporated Pharmaceutical compositions for buccal delivery of pain relief medications
US6375975B1 (en) 1998-12-21 2002-04-23 Generex Pharmaceuticals Incorporated Pharmaceutical compositions for buccal and pulmonary application
US6294153B1 (en) 1998-12-21 2001-09-25 Generex Pharmaceuticals, Inc. Aerosol pharmaceutical formulation for pulmonary and nasal delivery
US6350432B1 (en) 1999-03-19 2002-02-26 Generex Pharmaceuticals Incorporated Pressurized container having an aerosolized pharmaceutical composition
US6485706B1 (en) 1999-06-04 2002-11-26 Delrx Pharmaceutical Corp. Formulations comprising dehydrated particles of pharma-ceutical agents and process for preparing the same
GB2355009A (en) * 1999-07-30 2001-04-11 Univ Glasgow Peptides conjugated to bile acids/salts
EP2275557A1 (fr) 2000-04-12 2011-01-19 Human Genome Sciences, Inc. Protéines de fusion d'albumine
US8061006B2 (en) * 2001-07-26 2011-11-22 Powderject Research Limited Particle cassette, method and kit therefor
EP2990417A1 (fr) 2001-12-21 2016-03-02 Human Genome Sciences, Inc. Protéines de fusion d'albumine et insuline
EP1594530A4 (fr) 2003-01-22 2006-10-11 Human Genome Sciences Inc Proteines hybrides d'albumine
US8147426B2 (en) * 2003-12-31 2012-04-03 Nipro Diagnostics, Inc. Integrated diagnostic test system
JP2009539778A (ja) * 2006-06-08 2009-11-19 ダイアベコア メディカル インコーポレイテッド インスリンオリゴマー誘導体
WO2008112706A1 (fr) 2007-03-13 2008-09-18 Nutrition 21, Inc. Procédés et compositions utilisés pour la libération prolongée de chrome
JP5496082B2 (ja) * 2007-04-30 2014-05-21 ノボ・ノルデイスク・エー／エス タンパク質組成物を乾燥させる方法、乾燥タンパク質組成物、及び乾燥タンパク質を含有する薬学的組成物
WO2009002867A2 (fr) 2007-06-26 2008-12-31 Nutrition 21, Inc. Forme posologique à unités multiples contenant un agent thérapeutique en combinaison avec un complément alimentaire
EP2077132A1 (fr) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispositif distributeur, dispositif de stockage et procédé pour la distribution d'une formulation
US10011906B2 (en) 2009-03-31 2018-07-03 Beohringer Ingelheim International Gmbh Method for coating a surface of a component
EP3508239B1 (fr) 2009-05-18 2020-12-23 Boehringer Ingelheim International GmbH Adaptateur, dispositif d'inhalation et pulvérisateur
EA026241B1 (ru) 2009-11-25 2017-03-31 Бёрингер Ингельхайм Интернациональ Гмбх Распылитель
JP5658268B2 (ja) 2009-11-25 2015-01-21 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
JP5874724B2 (ja) 2010-06-24 2016-03-02 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
EP4070801A1 (fr) 2011-03-01 2022-10-12 Nutrition 21, LLC Compositions d'insuline et de chrome pour le traitement et la prévention du diabète, de l'hypoglycémie et de troubles apparentés
EP2694220B1 (fr) 2011-04-01 2020-05-06 Boehringer Ingelheim International GmbH Appareil médical pourvu d'un récipient
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013152894A1 (fr) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Pulvérisateur comprenant des moyens de détrompage
EP3030298B1 (fr) 2013-08-09 2017-10-11 Boehringer Ingelheim International GmbH Nébuliseur
ES2836977T3 (es) 2013-08-09 2021-06-28 Boehringer Ingelheim Int Nebulizador
AU2015258107B2 (en) 2014-05-07 2019-12-19 Boehringer Ingelheim International Gmbh Nebulizer
ES2874029T3 (es) 2014-05-07 2021-11-04 Boehringer Ingelheim Int Nebulizador
WO2015169732A1 (fr) 2014-05-07 2015-11-12 Boehringer Ingelheim International Gmbh Contenant, nébuliseur et utilisation
MX2018009748A (es) 2016-02-11 2019-02-07 Nutrition 21 Llc Composiciones que contienen cromo para mejorar la salud y el estado físico.

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE36225B1 (en) * 1971-01-28 1976-09-15 Nat Res Dev Improvements relating to insulin derivatives
GB1381273A (en) * 1971-01-28 1975-01-22 Nat Res Dev Insulin derivatives
GB1381274A (en) * 1971-01-28 1975-01-22 Nat Res Dev Insulin derivatives
DK135268A (fr) * 1973-02-09
GB1554157A (en) * 1975-06-13 1979-10-17 Takeda Chemical Industries Ltd Stable insulin preparation for intra nasal administration
US4164573A (en) * 1975-06-13 1979-08-14 Galinsky Alvin M Composition and method for making a suppository for introducing a hypoglycemic agent into a mammal
US4153689A (en) * 1975-06-13 1979-05-08 Takeda Chemical Industries, Ltd. Stable insulin preparation for nasal administration
GB1527605A (en) * 1975-08-20 1978-10-04 Takeda Chemical Industries Ltd Insulin preparation for intranasal administration
US4442090A (en) * 1980-11-09 1984-04-10 Kyoto Yakuhin Kogyo Kabushiki Kaisha Absorption-promoting compounds, compositions thereof with pharmaceuticals and/or bases for rectal administration and method of use
JPS58189118A (ja) * 1982-04-30 1983-11-04 Takeda Chem Ind Ltd 経鼻投与製剤
DE3382112D1 (de) * 1982-04-30 1991-02-21 Ajinomoto Kk Pharmazeutische zusammensetzung.
US4534894A (en) * 1982-11-17 1985-08-13 The Rockefeller University Process for sulphation and phosphorylation of proteins and peptides
JPS59163313A (ja) * 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
IL68769A (en) * 1983-05-23 1986-02-28 Hadassah Med Org Pharmaceutical compositions containing insulin for oral administration
US4746508A (en) * 1983-06-06 1988-05-24 Beth Israel Hospital Assn. Drug administration
JPS60224616A (ja) * 1984-04-24 1985-11-09 Teijin Ltd 経鼻投与用組成物

Also Published As

Publication number Publication date
DK160460B (da) 1991-03-18
DE3772521D1 (de) 1991-10-02
IL82209A0 (en) 1987-10-30
US5053389A (en) 1991-10-01
NO875299D0 (no) 1987-12-17
WO1987006137A1 (fr) 1987-10-22
DK642587A (da) 1987-12-08
EP0267208B1 (fr) 1991-08-28
ATE66614T1 (de) 1991-09-15
JPH01500116A (ja) 1989-01-19
AU598543B2 (en) 1990-06-28
FI875533A0 (fi) 1987-12-16
FI87529B (fi) 1992-10-15
AU7356187A (en) 1987-11-09
ES2007607A6 (es) 1989-07-01
FI87529C (fi) 1993-01-25
DK642587D0 (da) 1987-12-08
CA1283358C (fr) 1991-04-23
FI875533L (fi) 1987-12-16
EP0267208A1 (fr) 1988-05-18
DK160460C (da) 1991-08-26
NO875299L (no) 1987-12-17

Similar Documents

Publication Publication Date Title
DK642587D0 (da) Insulinpraeparat
PH23014A (en) Novel insulin derivatives,their use and pharmaceutical agents for the treatment of diabetes mellitus
HUP0002373A2 (hu) Glükagon antagonisták/inverz agonisták és ezeket tartalmazó gyógyászati készítmények
SE8504945L (sv) Farmaceutiska kompositioner innehallande antracyklinglykosider
AU1923088A (en) Piperazinyl derivatives of purines and isosteres thereof as hypoglycemic agents
NO904378L (no) Fremgangsmaate for fremstilling av et modifisert protein for terapeutisk anvendelse.
DE69011059D1 (de) Heterozyklische Acylaminothiazolderivate, ihre Herstellung und diese enthaltende pharmazeutische Zubereitungen.
DE19375061I2 (de) Hexadecylphosphocolin enthaltende arzneimittel mit antitumorwirkung.
DE68909409D1 (de) Heilmitteldosierung zur verabreichung an fische.
NO871295D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater.
EP0177342A3 (fr) Formulations orales de protéines thérapeutiques
AU601280B2 (en) Mixed crystals of insulin and insulin derivatives, a process for the preparation of these mixed crystals, pharmaceutical agents containing these mixed crystals, and the use thereof for the treatment of diabetes mellitus
IE890580L (en) Therapeutic agent for the prevention of intraventricular hemorrhage in premature infants
DK607885D0 (da) Medikamentpraeparatet med formindsket giftighed
DK0416678T3 (da) Topiske præparater indeholdende Defibrotid
BG44709A3 (bg) Метод за получаване на 9-хлор-1,5-бензотиазепинови производни
DE69015910D1 (de) Pharmazeutische Verwendung von Fettsäuren.
IT1226072B (it) Soluzioni iniettabili pronte all'uso contenenti un glicoside antraciclinico antitumorale.
ATE32882T1 (de) Phenylnonatetraensaeurederivate, ihre herstellung und pharmazeutische praeparate mit diesen derivaten.
DE3650368D1 (de) Verwendung von Depogen zur Behandlung von eingeschränktem Blutkreislauf.
FI843695A7 (fi) Insuliini-johdannaisia, joissa B 30-asema on modifioitu, menetelmiä niiden valmistamiseksi ja niiden käyttö sekä sokeritaudin hoitoon tarkoitettuja lääkeaineita.
DE3876425D1 (de) Gesteuerte verabreichung eines heilmittels an blut.
DE3788888D1 (de) Perhydrothiazepin- und Perhydroazepinderivate, ihre Herstellung und ihre therapeutische Verwendung.
EP0311467A3 (en) Use of pyrroloû3,2,1-hi¨indole derivatives in the manufacture of a medicament for the treatment of diabetes
ATE89000T1 (de) Pyrrolidinamid-derivate von acylaminosaeure, pharmazeutische zusammensetzung und verwendung.

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment